Turschner Simon, Efferth Thomas
German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Mini Rev Med Chem. 2009 Feb;9(2):206-2124. doi: 10.2174/138955709787316074.
Malaria, perhaps one of the most serious and widespread diseases encountered by mankind, continues to be a major threat to about 40 % of the world's population, especially in the developing world. As malaria vaccines remain problematic, chemotherapy still is the most important weapon in the fight against the disease. However, almost all available drugs have been compromised by the highly adaptable parasite, and the increasing drug resistance of Plasmodium falciparum continues to be the main problem. Therefore, the limited clinical repertoire of effective drugs and the emergence of multi-resistant strains substantiate the need for new anti-malarials. Plant-derived artemisinin is currently the only available drug that is globally effective, but alarmingly, recent studies suggest that resistance already may be developing. Nevertheless, the success story of artemisinin from the herb Qing Hao (Artemisia annua L.), used as a remedy in traditional Chinese medicine for more than two thousand years, shows once again that natural products serve as an invaluable reservoir of lead compounds for sophisticated small molecules. This review outlines the major anti-malarials, summarizing recent knowledge about their mode of action and the development of drug resistance. Furthermore, the most promising and recently discovered natural products with anti-malarial potential will be introduced.
疟疾或许是人类所面临的最严重且传播最广的疾病之一,仍然对全球约40%的人口构成重大威胁,在发展中世界尤为如此。由于疟疾疫苗仍存在问题,化疗仍是对抗该疾病的最重要武器。然而,几乎所有现有药物都受到了这种适应性极强的寄生虫的影响,恶性疟原虫耐药性的不断增加仍是主要问题。因此,有效药物的临床种类有限以及多重耐药菌株的出现凸显了研发新型抗疟药物的必要性。植物来源的青蒿素是目前全球唯一有效的药物,但令人担忧的是,最近的研究表明可能已经出现了耐药性。尽管如此,青蒿(黄花蒿)中的青蒿素作为中药已使用了两千多年,其成功再次表明天然产物是复杂小分子先导化合物的宝贵来源。本综述概述了主要的抗疟药物,总结了它们的作用模式及耐药性发展的最新知识。此外,还将介绍最有前景且最近发现的具有抗疟潜力的天然产物。